How to Create a Better Business Environment for Science and Technology Enterprises? Municipal Science and Technology Commission: Continue to Stimulate Vitality and Build an Open Innovation Ecosystem

Science and technology can likewise empower a first-class business environment. Take biomedicine, one of Shanghai’s three leading industries: it needs basic research at the front end, the transformation of results in the middle and the landing of applications at the back end, while the middle and back ends also need a strong atmosphere of “daring to act, daring to break new ground and daring to invest”.

 

On February 5, the first working day after the Spring Festival, the “Shanghai Action Plan for Focusing on Improving Corporate Experience and Continuing to Build a World-Class Business Environment” — the 8.0 version of Shanghai’s business environment action plan — was released as scheduled. There is no best business environment, only a better one. The Xinmin Evening News learned from the Shanghai Municipal Science and Technology Commission that in the next stage the Commission will, in line with the requirements of the World Bank’s new Business Ready (BR) assessment system, continue to stimulate the vitality of science and technology enterprises as market entities, build an open innovation ecosystem and optimize the business environment.

 

Reprinted from Shanghai Science and Technology

 

Science and technology can likewise empower a first-class business environment. Take biomedicine, one of Shanghai’s three leading industries: it needs basic research at the front end, the transformation of results in the middle and the landing of applications at the back end, while the middle and back ends also need a strong atmosphere of “daring to act, daring to break new ground and daring to invest”.

 

On February 5, the first working day after the Spring Festival, the “Shanghai Action Plan for Focusing on Improving Corporate Experience and Continuing to Build a World-Class Business Environment” — the 8.0 version of Shanghai’s business environment action plan — was released as scheduled. There is no best business environment, only a better one. The Xinmin Evening News learned from the Shanghai Municipal Science and Technology Commission that in the next stage the Commission will, in line with the requirements of the World Bank’s new Business Ready (BR) assessment system, continue to stimulate the vitality of science and technology enterprises as market entities, build an open innovation ecosystem and optimize the business environment.

 

The vitality of the biomedicine industry continues to burst forth

 

The biomedicine industry is in a phase of deep global industrial adjustment. As one of the three leading industries that Shanghai is vigorously developing, biomedicine has also faced multiple challenges in recent years. Over the past year, the Municipal Science and Technology Commission has made every effort to implement the new round of Shanghai’s plan for the biomedicine industry and has formulated and issued the “Several Opinions on Supporting the Full-Chain Innovative Development of the Biomedical Industry”. Shanghai’s biomedicine manufacturing industry has stabilized and recovered, continuing to improve.

 

The reporter learned that in 2024 the vitality of the city’s biomedicine industry continued to burst forth — the output value of biomedicine manufacturing reached RMB 201.167 billion, an increase of RMB 15.192 billion over the previous year, or 3.3% growth on a comparable basis; advantageous fields such as therapeutic biological products and medical imaging equipment grew well. Two biomedical enterprises, Xiaofang Pharmaceutical and Innostellar, were listed on the main board of the Shanghai Stock Exchange and on the STAR Market respectively. In addition, 7 domestic Class 1 innovative drugs were launched in the city (second in the country, accounting for 17.5% of the national total) and 3 imported Class 1 innovative drugs; 15 domestic Class III innovative medical devices were launched (first in the country, accounting for 32.6% of the national total) and 17 imported Class III innovative medical devices, with innovation results exceeding the same period of the previous year. There were 15 projects with overseas licensing transactions exceeding USD 500 million, with a transaction value of USD 19.833 billion, up 30.52% year on year and ranking first in the country.

 

“We pushed for the signing of projects such as Qianjian Guoke and Syngenta Group, supported high-level projects of companies such as Roche and Daiichi Sankyo in increasing investment, promoted the start of construction of a number of projects including the global R&D headquarters of Hansoh Pharma, and saw the completion of a number of projects such as the Boston Scientific manufacturing base and the Intuitive Fosun headquarters and industrialization base,” introduced a relevant person in charge of the Municipal Science and Technology Commission.

 

A “small incision” leveraging “big gains”

 

It is well known that the transformation of scientific and technological achievements is not easy, yet once successfully transformed and implemented, both sides can expect huge returns. Whether a “shop assistant” can do something to make this path smoother is crucial.

 

The reporter noted that Shanghai is deepening the reform of the property rights system for scientific and technological achievements, with a “small incision” now leveraging “big gains” — implementing the “Implementation Plan for the Pilot of Innovative Reform in the Transformation of Scientific and Technological Achievements in Shanghai”, promoting reform measures such as granting full ownership under “granting ownership + transfer + agreement” and compliant entrepreneurship, and encouraging pilot units to establish supporting institutional guidelines such as separate management of scientific and technological achievements and exemption from liability for due diligence. The pilot stage of the reform achieved remarkable results in 2024: 39 pilot units — universities, research institutes and medical and health institutions — were granted rights over 185 achievements, including 82 with full ownership granted, with a transformation value of RMB 1.09 billion, and 149 companies were set up through researchers’ independent entrepreneurship or compliant restructuring, attracting investment and financing of RMB 6.8 billion.

 

Encouragingly, a number of representative transformation cases have emerged: the value of scientific and technological achievements transformed by East China Normal University through licensing, transfer and investment in kind increased from RMB 7.08 million in 2023 to RMB 476 million in 2024; after Shanghai University of Science and Technology issued its rights-granting document, the first fully rights-granted achievement, the “humanoid robot project”, completed RMB 100 million in financing in only two months; Ruijin Hospital concluded two transformation contracts worth RMB 100 million or more, reaching a RMB 270 million transformation agreement with Shanghai Pharmaceuticals Ruier on a “gene therapy for hemophilia” technical solution and a RMB 100 million patent package transformation cooperation with Shanghai RAAS Blood Products on “coagulation and anticoagulation drugs”…

 

Helping to solve all kinds of difficulties

 

“We will continue to give play to the exemplary and driving role of high-quality incubators and help solve various difficulties in advancing investment and financing, scenario application, professional platform construction and overseas expansion,” said the relevant person in charge of the Municipal Science and Technology Commission, adding that the Commission will continue to select and lay out high-quality incubators, launching each one as it matures, and actively seize the new high ground of incubation and development for future industries.

 

At the same time, the Commission will actively build an ecosystem of professional technology managers and support the Shanghai Technology Exchange in building a national trading center for intellectual property and scientific and technological achievement property rights; it will build an international technology transfer collaboration network to promote global information exchange and the transformation and application of scientific and technological achievements.

 

The reporter also learned that the Commission will improve the mechanism supporting the development of innovative drugs, better leverage their clinical benefits and enhance people’s wellbeing. Relying on the comprehensive reform advantages of Pudong New Area and seeking the support of relevant national departments, it will take the lead in carrying out reform on the hospital admission and use of innovative drugs. Adhering to the basic principles of putting people first, giving priority to innovation, piloting first and keeping risks controllable, and focusing on key links such as the hospital admission, use, pricing, payment and review and approval of innovative drugs, it will strengthen the coordination of the “three medicals” and, with the stance of a pioneer and the responsibility of a forerunner, actively “test systems, measure pressure and explore new paths” for the country, accelerate the building of a biomedical industry innovation highland with global influence, and cultivate and develop new quality productive forces.

 


Source: Shangguan News 

Author: Gao Yang, Xinmin Evening News

Editor: Shi